Insider · CIK 0001468308
Robert Andrade
Files at FENC (FENNEC PHARMACEUTICALS INC.). First filing Aug 28, 2026, latest Aug 28, 2026.
In brief
Robert Andrade files SEC Form 4 as CFO at FENC (FENNEC PHARMACEUTICALS INC.). Since Aug 28, 2026, Robert Andrade has reported 0 open-market buys worth $0 and 1 open-market sell worth $884k, the latest filed on Aug 28, 2026.
A track record needs three past buys with six months of prices behind them; Robert Andrade has 0, so none is measured yet.
The newest scored trade: sold $884k of FENC on Aug 27, 2026, filed Aug 28, 2026, scored 35 (weak), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 1 sell worth $884k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
FENC: FENNEC PHARMACEUTICALS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 35Weak | FENNEC PHARMACEUTICALS INC. | $884k 75,000 shares | -26% | +104% from low-8% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Aug 27, 2026 | FENC FENNEC PHARMACEUTICALS INC. | 75,000 0.21% of outstanding | $884k | Aug 27, 2026 | none |
Transactions
Every row this insider has filed, 48 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,703 | $0.00 | $0 | 243,009 | 12 d ago |
| Aug 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,703 | $0.00 | $0 | 241,306 | 43 d ago |
| Aug 27, 2026 | FENC FENNEC PHARMACEUTICALS INC. | SOpen-market sale Common shares10b5-1 | -75,000 | $11.78 | $884k | 217,675 | Aug 28, 2026 |
| Aug 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares10b5-1 | +21,928 | $5.10 | $112k | 239,603 | Aug 28, 2026 |
| Aug 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative10b5-1 | -21,928 | $0.00 | $0 | 779,330 | Aug 28, 2026 |
| Jul 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,703 | $0.00 | $0 | 292,675 | Aug 3, 2026 |
| Jun 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,703 | $0.00 | $0 | 290,972 | Jul 1, 2026 |
| May 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,703 | $0.00 | $0 | 289,269 | Jun 1, 2026 |
| Apr 30, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +1,703 | $0.00 | $0 | 287,566 | May 1, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +14,724 | $0.00 | $0 | 271,380 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +2,213 | $0.00 | $0 | 273,593 | Apr 2, 2026 |
| Mar 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +12,270 | $0.00 | $0 | 285,863 | Apr 2, 2026 |
| Mar 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +120,000 | $5.77 | $692k | 921,045 | Apr 2, 2026 |
| Mar 26, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +13,072 | $5.10 | $67k | 256,656 | Mar 26, 2026 |
| Mar 26, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -13,072 | $5.10 | $67k | 801,045 | Mar 26, 2026 |
| Feb 28, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,191 | $0.00 | $0 | 243,584 | Mar 3, 2026 |
| Feb 18, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +2,450 | $4.08 | $9,996 | 215,108 | Feb 19, 2026 |
| Feb 18, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +27,285 | $0.00 | $0 | 242,393 | Feb 19, 2026 |
| Feb 18, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -2,450 | $4.08 | $9,996 | 814,117 | Feb 19, 2026 |
| Jan 31, 2026 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,558 | $0.00 | $0 | 212,658 | Feb 2, 2026 |
| Jan 23, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +10,000 | $2.45 | $25k | 211,100 | Jan 23, 2026 |
| Jan 23, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -10,000 | $2.45 | $25k | 816,567 | Jan 23, 2026 |
| Jan 15, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +10,000 | $2.45 | $25k | 201,100 | Jan 15, 2026 |
| Jan 15, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -10,000 | $2.45 | $25k | 826,567 | Jan 15, 2026 |
| Jan 7, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +14,184 | $2.45 | $35k | 191,100 | Jan 7, 2026 |
| Jan 7, 2026 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -14,184 | $2.45 | $35k | 836,567 | Jan 7, 2026 |
| Dec 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,382 | $0.00 | $0 | 176,916 | Jan 5, 2026 |
| Dec 1, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,430 | $0.00 | $0 | 175,534 | Dec 2, 2025 |
| Oct 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,430 | $0.00 | $0 | 173,104 | Nov 3, 2025 |
| Sep 30, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,430 | $0.00 | $0 | 170,674 | Oct 1, 2025 |
| Aug 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,431 | $0.00 | $0 | 168,244 | Sep 2, 2025 |
| Jul 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,431 | $0.00 | $0 | 165,813 | Aug 1, 2025 |
| Jun 30, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,431 | $0.00 | $0 | 163,382 | Jul 1, 2025 |
| May 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +2,431 | $0.00 | $0 | 160,951 | Jun 2, 2025 |
| May 22, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +8,220 | $5.10 | $42k | 158,520 | May 23, 2025 |
| May 22, 2025 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -8,220 | $5.10 | $42k | 850,751 | May 23, 2025 |
| May 16, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +16,667 | $0.00 | $0 | 150,300 | May 19, 2025 |
| Apr 30, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 133,633 | May 1, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Restricted Share Unitderivative | +75,000 | $0.00 | $0 | 827,722 | Apr 3, 2025 |
| Mar 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +50,000 | $0.00 | $0 | 877,722 | Apr 3, 2025 |
| Mar 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 132,591 | Apr 1, 2025 |
| Feb 28, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 131,549 | Feb 28, 2025 |
| Jan 31, 2025 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 130,507 | Feb 3, 2025 |
| Dec 31, 2024 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 129,465 | Jan 3, 2025 |
| Dec 2, 2024 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 128,423 | Dec 2, 2024 |
| Nov 18, 2024 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Common shares | +15,816 | $2.45 | $39k | 127,381 | Nov 18, 2024 |
| Nov 18, 2024 | FENC FENNEC PHARMACEUTICALS INC. | MOption exercise Stock Optionsderivative | -15,816 | $2.45 | $39k | 689,184 | Nov 18, 2024 |
| Oct 31, 2024 | FENC FENNEC PHARMACEUTICALS INC. | AGrant or award Common shares | +1,042 | $0.00 | $0 | 111,565 | Nov 4, 2024 |
Questions about Robert Andrade
Answered from the filings on this page, as of the latest one.
Is Robert Andrade buying or selling?
In the last 12 months Robert Andrade reported 0 open-market buys worth $0 and 1 open-market sell worth $884k on SEC Form 4; the latest was sold $884k of FENC on Aug 27, 2026. Grants, option exercises and tax withholding are not counted.
How did Robert Andrade's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Andrade has 0.
Where does Robert Andrade file Form 4?
Robert Andrade has filed Form 4 at FENC (FENNEC PHARMACEUTICALS INC.) as CHIEF FINANCIAL OFFICER. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.